Keyneurotek Pharmaceuticals AG
Records under this name other than patents Keyneurotek Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Keyneurotek Pharmaceuticals AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,670,576 | Device and method for measuring impedance in organotypic tissues Formerly held Lapsed on the fee record Ended Jun 2, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2024 | USPTO record |
| US 8,263,636 | Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases Lapsed on the fee record Ended Sep 11, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 11, 2016 | USPTO record |
| US 7,291,599 | Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases Formerly held Lapsed on the fee record Ended Nov 6, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 6, 2015 | USPTO record |
| US 7,858,655 | Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases Lapsed on the fee record Ended Dec 28, 2014 · USPTO record | Lapsed on the fee record | Ended Dec 28, 2014 | USPTO record |